Loading…

Salivary Microbiota is Associated with Cannabis Use in Adolescents

Purpose Cannabis is now the second most commonly used substance during adolescence, with 35.7% of 18‐year‐olds reporting use in the past year and 6.4% reporting daily use. Accumulating evidence suggests that cannabis use affects the microbiome, however, this is still underexplored. Given that adoles...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2022-05, Vol.36 (S1), p.n/a
Main Authors: Browning, Brittney D., Kirkland, Anna, Liu, Helen, Green, ReJoyce, Ticer, Taylor, Glover, Janiece, Engevik, Melinda, Squeglia, Lindsay
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Cannabis is now the second most commonly used substance during adolescence, with 35.7% of 18‐year‐olds reporting use in the past year and 6.4% reporting daily use. Accumulating evidence suggests that cannabis use affects the microbiome, however, this is still underexplored. Given that adolescence is a vital period of neural and microbial development, it is essential to investigate if cannabis use is associated with differences in microbiota as perturbations to microbial systems during this period of development may influence brain development. Methods Saliva biospecimens were collected from adolescent (15‐19 years old) cannabis users (N=8) and control participants (N=9) in an ongoing clinical trial (K23 AA025399) at the Medical University of South Carolina. Bacterial quantification was performed by real‐time quantitative PCR (qPCR) using primers for representative oral phyla (Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria) and related species (Staphylococcus, Clostridium coccoides, Clostridium leptum, Lactobacillus, Escherichia coli, Bacteroides, and Prevotella). Standard t‐test was used to compare the relative abundances between the cannabis using group and control group. Correlations between levels of oral phyla and related species with cannabis use days reported on the Timeline Follow back (TLFB) and Cannabis Use Disorder Identification Test (CUDIT) scores were completed. Results All saliva samples contained significant levels of bacterial gDNA (mean concentration: 96.9 ng/μl; ~10 ng/μl is sufficient). We observed significantly lower levels of Proteobacteria (p=0.031) and Bacteroides (p= 0.006) in the cannabis‐using group compared to the non‐cannabis‐using control group. Additionally, the number of cannabis use days reported on the TLFB and CUDIT scores were inversely correlated with Bacteroides levels (p=
ISSN:0892-6638
1530-6860
DOI:10.1096/fasebj.2022.36.S1.L7501